Fny Investment Advisers, LLC Acelrx Pharmaceuticals Inc Call Options Transaction History

Fny Investment Advisers, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2019 Jan 10, 2020	SELL	$1.66 - $2.4 $83 - $120	-50 Closed	0 $0
Q3 2019 Oct 25, 2019	BUY	$2.1 - $2.87 $105 - $143	50 New	50 $0
Q2 2019 Jul 24, 2019	SELL	$2.1 - $3.93 $105 - $196	-50 Closed	0 $0
Q1 2019 Apr 17, 2019	SELL	$2.35 - $3.83 $11 - $19	-5 Reduced 9.09%	50 $0
Q4 2018 Jan 22, 2019	BUY	$2.13 - $4.8 $106 - $240	50 Added 1000.0%	55 $0
Q2 2018 Jul 18, 2018	BUY	$2.13 - $4.2 $10 - $21	5 New	5 $0

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.